Cargando…

Pulmonary hypertension in connective tissue diseases, new evidence and challenges

Pulmonary arterial hypertension is a lethal complication of different connective tissue diseases such as systemic sclerosis, mixed connective tissue disease and systemic lupus erythematosus. Although the treatment possibilities for patients with pulmonary arterial hypertension have increased in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vonk, Madelon C., Vandecasteele, Els, van Dijk, Arie P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988614/ https://www.ncbi.nlm.nih.gov/pubmed/33216992 http://dx.doi.org/10.1111/eci.13453

Ejemplares similares

Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
por: Dhont, Sebastiaan, et al.
Publicado: (2022)

Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties
por: Lemmers, Jacqueline M.J., et al.
Publicado: (2022)

Connective tissue disease-associated pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2015)

Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Moccaldi, Beatrice, et al.
Publicado: (2023)

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases
por: Smukowska-Gorynia, Anna, et al.
Publicado: (2023)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

Selexipag treatment in patients with systemic sclerosis–associated pulmonary arterial hypertension in clinical practice, a case series
por: Lemmers, Jacqueline MJ, et al.
Publicado: (2020)

Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
por: Overbeek, Maria J, et al.
Publicado: (2011)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Pulmonary hypertension
por: Vonk Noordegraaf, Anton, et al.
Publicado: (2016)

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
por: Grünig, Ekkehard, et al.
Publicado: (2012)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
por: Gaine, Sean, et al.
Publicado: (2017)

Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study
por: Lemmers, Jacqueline MJ, et al.
Publicado: (2023)

The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease
por: Xiong, Jiangbiao, et al.
Publicado: (2022)

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
por: Coghlan, J Gerry, et al.
Publicado: (2014)

Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients
por: Cavagna, Lorenzo, et al.
Publicado: (2016)

Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
por: Niklas, Karolina, et al.
Publicado: (2018)

Cardiac magnetic resonance imaging in pulmonary arterial hypertension
por: Peacock, Andrew J., et al.
Publicado: (2013)

Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
por: Sitbon, Olivier, et al.
Publicado: (2014)

The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges
por: Swisher, John W, et al.
Publicado: (2023)

Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience
por: Sitbon, Olivier, et al.
Publicado: (2017)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension
por: Dong, Xingbei, et al.
Publicado: (2022)

Pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials
por: Kuwana, Masataka, et al.
Publicado: (2013)

Significant Clinical Indexes of Exercise-Induced Pulmonary Hypertension in Patients With Connective Tissue Disease
por: Ojima, Satoko, et al.
Publicado: (2019)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: van Uden, Denise, et al.
Publicado: (2019)

Pulmonary hypertension: diagnostic and therapeutic challenges
por: Bazan, Isabel S, et al.
Publicado: (2015)

Pulmonary Hypertension in Pregnancy: Challenges and Solutions
por: Afify, Hesham, et al.
Publicado: (2022)

The challenges in paediatric pulmonary arterial hypertension
por: Beghetti, Maurice, et al.
Publicado: (2014)

Treatment strategies for the right heart in pulmonary hypertension
por: Westerhof, Berend E., et al.
Publicado: (2017)

Genetic Background of Hypertension in Connective Tissue Diseases
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2020)

The outcome of pulmonary hypertension and its association with pulmonary artery dilatation
por: Duijnhouwer, A. L., et al.
Publicado: (2020)

Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease
por: Richards, Carl D., et al.
Publicado: (2019)

Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease
por: McGettrick, Michael, et al.
Publicado: (2020)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

Prevalence of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review of the literature
por: Yang, Xiaoqin, et al.
Publicado: (2013)

Reduced RVSWI Is Associated With Increased Mortality in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
por: Clapham, Katharine R., et al.
Publicado: (2020)

Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
por: Nakayama, Kazuhiko, et al.
Publicado: (2021)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krq7gg10ug2t42sl7rbrf4ep6g